Story at a glance

  • BioNTech’s chief medical adviser says data from clinical trials including children ages 5 to 11 could be released this summer.
  • “We will then file it with the regulators and, depending on how fast they react, by the end of the year we might get approval to also immunize younger children,” Tureci told CNBC.
  • Pfizer and BioNTech kicked off clinical trials of their vaccine in children between the age of 6 months and 11 years old late last month.

BioNTech’s co-founder and chief medical officer says data on how effective the Pfizer-BioNTech COVID-19 vaccine is in children ages 5 to 11 could be released by the end of summer. 

In an interview with CNBC Thursday, Ozlem Tureci said young children could begin getting vaccinated with the Pfizer vaccine by the end of this year if it receives approval from the Food and Drug Administration (FDA). 


Our country is in a historic fight against the Coronavirus. Add Changing America to your Facebook or Twitter feed to stay on top of the news.


“We expect the data at the end of the summer or autumn of this year. We will then file it with the regulators and, depending on how fast they react, by the end of the year we might get approval to also immunize younger children,” Tureci told the news outlet. 

Pfizer and BioNTech kicked off clinical trials of their vaccine in children between the age of 6 months and 11 years old in late March. The companies are evaluating older age groups in that range first so data on children under age 5 may come later, Tureci told CNBC.

The two pharmaceutical companies on Friday announced they submitted a request to European drug regulators for the approval of their vaccine to be extended to include children 12 to 15 years old. 

The companies recently announced clinical trials showed their vaccine to be 100 percent effective in children ages 12 to 15. 

The vaccine was effective and generated robust antibody responses in a clinical trial of 2,260 adolescents. 

Currently, the two-dose vaccine is authorized for use in people 16 and older in the U.S. 


READ MORE STORIES FROM CHANGING AMERICA

COVID-RECOVERED PEOPLE MAY ONLY NEED ONE DOSE OF PFIZER OR MODERNA VACCINES

CDC GIVES NEW MASK GUIDANCE FOR OUTDOORS AND INDOORS

CDC INVESTIGATING NEW REPORTS OF BLOOD CLOT CASES LINKED TO J&J VACCINE

SOME US VACCINATION SITES ARE SHUTTING DOWN BECAUSE UNVACCINATED PEOPLE AREN’T WILLING TO GET THEIR SHOTS

PFIZER-BIONTECH BOOSTER LIKELY NEEDED AS IMMUNITY WANES, SAYS SCIENTIST WHO HELPED DEVELOP VACCINE


 

Published on Apr 30, 2021